Approval · Notice of Compliance 443 · 2002
HONVOL: Notice of Compliance 443
Issued June 6, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 443
- Date
- June 6, 2002
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Treatment of prostatic carcinoma
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HONVOL | 02241793 | — |
| HONVOL | 02241794 | — |
Medicinal ingredients
- DIETHYLSTILBESTROL DIPHOSPHATE SODIUM 50 MG per ML
- DIETHYLSTILBESTROL DIPHOSPHATE SODIUM 83 MG per TAB